Price revision of medicines entered into force

Price revision of medicines entered into force - 

On January 1, new prices for non-generic medicines entered into force, which are established on the basis of those in force in three countries of reference - Spain, France and Italy - as set forth in a ruling, according to the national authority of the medicinal product and health products (INFARMED).

The review does not provide for price increases in medicines, but reductions of up to 10% of the retail price (PVP).

In the case of generic medicines, the review will take effect in February and will cover those with a PVP above the maximum PVP of the reference drug.

 

 Source: Website of the "Medical Journal" and author on  January 02, 2018